LB1148
Phase 3-ready- Indications
- Postoperative gastrointestinal dysfunction, Postoperative adhesions
Company intelligence / Profile preview
Seneca Biopharma
Germantown, Maryland, United Statessenecabio.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Seneca Biopharma was a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Its legacy included a technology platform enabling the generation and commercial-scale production of regionally specific neural stem cell lines, with applications in therapeutic indications or drug screening. The company shifted focus from neurological disorders to acquiring new assets/technologies before merging with Leading BioSciences in late 2020 to form Palisade Bio. No recent independent clinical results are available post-merger.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Cell therapyMonoclonal antibodySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
QYuns Therapeutics
Beyond the preview
Go deeper on Seneca Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Seneca Biopharma.